Use of imaging modalities for decision-making in inflammatory bowel disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Therapeutic Advances in Gastroenterology Année : 2023

Use of imaging modalities for decision-making in inflammatory bowel disease

Résumé

Cross-sectional magnetic resonance enterography (MRE) and intestinal ultrasonography (IUS) provide valuable and noninvasive information to accurately assess disease activity, severity, and extent; detect complications; and monitor the response to treatment, as well as predict the postoperative recurrence of Crohn’s disease and a negative disease course. Therefore, both imaging modalities are emerging as pivotal diagnostic tools to achieve the emerging therapeutic target of transmural healing associated with better disease outcomes. Despite its numerous potential advantages over endoscopy and even MRE and its good availability, IUS is still widely underused to monitor and manage inflammatory bowel disease (IBD) patients and help in making clinical decisions in routine practice. This situation is clearly due to the absence of validated, reliable, and responsive indices, as well as the lack of trained gastroenterologists and radiologists, as IUS is a component of radiologist expertise in several countries but not yet integrated into the training program of gastroenterologists. However, there is an increasing body of evidence in the literature that IUS and MRE are both becoming essential imaging resources to help clinicians in making reliable decisions. Here, we discuss the up-to-date evidence about the usefulness and performance of cross-sectional imaging, focusing on the ability of bowel US and MRE to aid clinical decision-making for the optimal management and monitoring of IBD.
Fichier non déposé

Dates et versions

hal-03992450 , version 1 (16-02-2023)

Identifiants

Citer

Stéphane Nancey, Mathurin Fumery, Mathias Faure, Gilles Boschetti, Claire Gay, et al.. Use of imaging modalities for decision-making in inflammatory bowel disease. Therapeutic Advances in Gastroenterology, 2023, 16, pp.175628482311512. ⟨10.1177/17562848231151293⟩. ⟨hal-03992450⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More